Trial Profile
The treatment of insomnia in symptomatic peri- and postmenopausal women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Anxiety; Depression; Hot flashes; Insomnia
- Focus Therapeutic Use
- 12 Jan 2010 Results were presented in the American Journal of Obstetrics and Gynecology.
- 22 Dec 2007 Status changed from in progress to completed.
- 23 Oct 2006 New trial record.